ZENTALIS PHARMACEUTICALS INC (ZNTL)

US98943L1070 - Common Stock

3  +0.07 (+2.39%)

After market: 3 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to ZNTL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 9.69. This target is 223% above the current price.
ZNTL was analyzed by 17 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ZNTL.
In the previous month the buy percentage consensus was at a similar level.
ZNTL was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 3.004.048.169.6921.00 - 34.67% 172.00% 223.00% 600.00%
Up and Down Grades
Date Firm Action Rating
2024-11-15 Guggenheim Maintains Buy -> Buy
2024-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-16 Oppenheimer Reiterate Outperform -> Outperform
2024-08-12 Wedbush Upgrade Underperform -> Neutral
2024-08-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-20 UBS Downgrade Buy -> Neutral
2024-06-18 Oppenheimer Maintains Outperform -> Outperform
2024-06-18 Stifel Maintains Buy -> Buy
2024-06-18 Wells Fargo Downgrade Overweight -> Equal-Weight
2024-06-18 Morgan Stanley Downgrade Overweight -> Equal-Weight
2024-06-18 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-08 Stifel Maintains Buy -> Buy
2024-05-08 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-28 Wedbush Maintains Neutral -> Neutral
2024-02-28 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-08 Wedbush Downgrade Outperform -> Neutral
2023-11-07 Stifel Maintains Buy -> Buy
2023-11-07 Morgan Stanley Maintains Overweight -> Overweight
2023-11-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-10 Wedbush Reiterate Outperform -> Outperform
2023-08-10 Wells Fargo Maintains Overweight -> Overweight
2023-08-10 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-07 Stifel Maintains Buy -> Buy
2023-06-07 Wedbush Reiterate Outperform -> Outperform
2023-05-26 Oppenheimer Reiterate Outperform -> Outperform
2023-05-26 Wedbush Maintains Outperform -> Outperform
2023-05-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-19 Jefferies Maintains Buy -> Buy
2023-05-11 Oppenheimer Reiterate Outperform -> Outperform
2023-05-11 HC Wainwright & Co. Reiterate Buy -> Buy